To determine whether immunosuppressive TAMs are more predominant in BRCA1-deficient breast cancers than in ovarian cancers, we compared treatment-naïve mouse breast and ovarian BRCA1-deficient tumors. Here, BRCA1 is linked to breast carcinoma.